Your editorial (August 18) and subsequent correspondence about drug-pricing and cost to the NHS seek to cover wide territory.
Your editorial (August 18) and subsequent correspondence about drug-pricing and cost to the NHS seek to cover wide territory. The chairman of the National Institute for Clinical Excellence (Nice) has criticised some of the prices set by pharmaceutical companies for low-volume, high-cost items such as new drugs to treat cancer.
Your editorial (August 18) and subsequent correspondence about drug-pricing and cost to the NHS seek to cover wide territory.